(Q43820743)

27 November 2017

title

Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. (English)

1 reference

27 November 2017

1 reference

1 reference

5

1 reference

27 November 2017

6

1 reference

27 November 2017

9

1 reference

27 November 2017

David Saadoun

1

0 references

Jean-Charles Piette

series ordinal

7

object named as

Jean-Charles Piette

1 reference

27 November 2017

8

Patrick Marcellin

1 reference

27 November 2017

3

Mathieu Resche-Rigon

1 reference

27 November 2017

4

Frédéric Charlotte

1 reference

27 November 2017

2

Tarik Asselah

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

27 November 2017

1 reference

27 November 2017

volume

43

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

1337-1345

1 reference

Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis

27 November 2017

cites work

1 reference

Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia

21 January 2018

1 reference

Epidemiology of hepatitis C: geographic differences and temporal trends

21 January 2018

1 reference

7 January 2021

Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients

1 reference

7 January 2021

Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.

1 reference

7 January 2021

Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage.

1 reference

7 January 2021

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

1 reference

7 January 2021

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

1 reference

7 January 2021

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients

1 reference

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

7 January 2021

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

1 reference

7 January 2021

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

1 reference

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

7 January 2021

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

7 January 2021

The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection

1 reference

7 January 2021

Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity

1 reference

7 January 2021

Biologic and clinical significance of cryoglobulins. A report of 86 cases

1 reference

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

7 January 2021

Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia

1 reference

7 January 2021

Enhanced monocyte Th1 cytokine production in HCV-infected cryoglobulinemic patients

1 reference

7 January 2021

Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis.

1 reference

7 January 2021

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

1 reference

7 January 2021

Steatosis affects chronic hepatitis C progression in a genotype specific way

1 reference

7 January 2021

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

1 reference

7 January 2021

Nonalcoholic fatty liver disease

1 reference

7 January 2021

Host- and disease-specific factors affecting steatosis in chronic hepatitis C

1 reference

7 January 2021

STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?

1 reference

7 January 2021

Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

1 reference

7 January 2021

Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

1 reference

7 January 2021

Hepatic steatosis and type 2 diabetes mellitus

1 reference

7 January 2021

A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany

1 reference

7 January 2021

CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis.

1 reference

7 January 2021

1 reference

7 January 2021

Attenuated liver fibrosis in the absence of B cells

1 reference

7 January 2021

Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21190

1 reference

27 November 2017

1 reference